Literature DB >> 4704063

Erythrocyte osmotic fragility in hyperthermia-susceptible swine.

G G Harrison, C Verburg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4704063     DOI: 10.1093/bja/45.2.131

Source DB:  PubMed          Journal:  Br J Anaesth        ISSN: 0007-0912            Impact factor:   9.166


× No keyword cloud information.
  8 in total

1.  Increased membrane fluidity of erythrocytes in a case with malignant hyperthermia.

Authors:  M Kawamoto; K Fujii; H Kikuchi; M Morio
Journal:  J Anesth       Date:  1987-03-01       Impact factor: 2.078

Review 2.  Etiopathogenetic defect of malignant hyperthermia: hypersensitive calcium-release channel of skeletal muscle sarcoplasmic reticulum.

Authors:  P J O'Brien
Journal:  Vet Res Commun       Date:  1987       Impact factor: 2.459

3.  Open canalicular system of platelets in porcine stress syndrome.

Authors:  P K Basrur; A Bouvet; W N McDonell
Journal:  Can J Vet Res       Date:  1988-07       Impact factor: 1.310

4.  Platelet alterations in porcine stress syndrome.

Authors:  A Bouvet; S Yamashiro; W N McDonell; P K Basrur
Journal:  Vet Res Commun       Date:  1987       Impact factor: 2.459

Review 5.  Malignant hyperthermia: molecular defects in membrane permeability.

Authors:  K S Cheah; A M Cheah
Journal:  Experientia       Date:  1985-05-15

6.  Canine malignant hyperthermia susceptibility: erythrocytic defects--osmotic fragility, glucose-6-phosphate dehydrogenase deficiency and abnormal Ca2+ homeostasis.

Authors:  P J O'Brien; G W Forsyth; D W Olexson; H S Thatte; P B Addis
Journal:  Can J Comp Med       Date:  1984-10

7.  Effects of anaesthetic agents on erythrocyte fragility: comparison of normal and malignant hyperthermia susceptible patients.

Authors:  E I Tolpin; J E Fletcher; H Rosenberg; K Michaux
Journal:  Can J Anaesth       Date:  1987-07       Impact factor: 5.063

8.  A case of suspected malignant hyperthermia.

Authors:  Cg Ravindra; M Kiran; Gl Ravindra
Journal:  Indian J Anaesth       Date:  2013-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.